|
Status |
Public on Apr 22, 2008 |
Title |
CCRF-CEM CompE 24h rep2 |
Sample type |
RNA |
|
|
Source name |
CCRF-CEM Human T-cell lymphoblastic cell line gamma-secretase inhibitor (CompE 500nM) treatment 24h
|
Organism |
Homo sapiens |
Characteristics |
T-cell acute lymphoblastic leukemia cell line
|
Biomaterial provider |
T-cell acute lymphoblastic leukemia cell line from ATCC
|
Treatment protocol |
Compound E (CompE) [ (2S)-2-{[ (3,5-Difluorophenyl)acetyl]amino}-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl] propanamide] (Alexis Biochemicals) a cell permeable, potent, selective, non-transition state and non-competitive inhibitor of gamma-secretase treatment at 500nM in DMSO for 24h.
|
Growth protocol |
Cells were cultured in RPMI1640 media supplemented with 10% fetal bovine serum plus antibiotics (pen/strep) in a humidified incubator with 5% CO2 atmosphere at 37C
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with RNAqueous minikit (Ambion) following the manufacturer’s instructions
|
Label |
biotin
|
Label protocol |
Approx. 10micrograms of total RNA was processed to produce biotinylated cRNA targets
|
|
|
Hybridization protocol |
Standard Affymetrix procedure
|
Scan protocol |
Standard Affymetrix procedure
|
Description |
Standard Affymetrix procedure
|
Data processing |
Affymetrix Microarray Suite Version 5 followed by Dchip data normalization for adjustment of interarray intensity differences and calculation of model based expression (VALUE).
|
|
|
Submission date |
Aug 31, 2006 |
Last update date |
Apr 22, 2008 |
Contact name |
Adolfo A Ferrando |
E-mail(s) |
[email protected]
|
Phone |
212-851-4611
|
Organization name |
Columbia University
|
Department |
Institute for Cancer Genetics
|
Street address |
1130 St Nicholas Ave Irving Cancer Research Center 5-505A
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10032 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (2) |
GSE5716 |
Gene expression analysis of T-ALL cell lines treated with gamma-secretase inhibitor |
GSE5827 |
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth |
|